Suppr超能文献

转染编码变异P-糖蛋白和谷胱甘肽S-转移酶π的人类基因的细胞中的多药耐药性

Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.

作者信息

Fairchild C R, Moscow J A, O'Brien E E, Cowan K H

机构信息

Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.

出版信息

Mol Pharmacol. 1990 Jun;37(6):801-9.

PMID:1972772
Abstract

The nucleotide sequence of the mdr1 gene encoding a putative drug efflux pump (P-glycoprotein) is homologous to a class of bacterial membrane-associated transport proteins. These bacterial proteins are part of a multicomponent system that includes soluble periplasmic proteins that bind substrates, channeling them through the membrane in an energy-dependent manner. We have investigated the possibility that a similar multicomponent transport system exists in a multidrug-resistant human MCF-7 breast cancer cell line that was initially selected for resistance to doxorubicin (AdrR MCF-7). AdrR MCF-7 cells overexpress both the mdr1 gene and the pi class isozyme of glutathione S-transferase (GST-pi) (EC 2.5.1.18). The latter is one of several isozymes known to have a ligand-binding function in addition to drug-metabolizing capabilities. Although we have recently shown that transfection of a functional GST-pi expression vector is insufficient to confer resistance to doxorubicin in cells that lack P-glycoprotein expression [Mol. Pharmacol. 36:22-28 (1989)], we examined the possibility that GST-pi interacts with P-glycoprotein to alter multidrug resistance. To do this, we have cloned cDNAs encoding these proteins from AdrR MCF-7 cells, constructed expression vectors containing these two genes, and transfected these vectors sequentially into drug-sensitive MCF-7 cells. The human mdr1 cDNA isolated from AdrR MCF-7 is a variant gene whose sequence differs from that isolated previously from vinblastine-resistant KB cells [Cell 53:519-529 (1989)], resulting in an amino acid substitution of alanine to serine at position 893 (mdr1/893ala). Transfection of eukaryotic expression vectors containing the mdr1 gene isolated from AdrR MCF-7 cells produced a multidrug-resistant phenotype in recipient cells, with a cross-resistance pattern similar to that in the AdrR MCF-7 cells. To determine whether GST-pi expression could augment resistance provided by mdr1, two clones transfected with mdr1, one with high levels (153% of mdr1 RNA in AdR MCF-7 cells) and one with low levels (10% of mdr1 RNA in AdrR MCF-7 cells), were subsequently cotransfected with a GST-pi expression vector and pSVNeo and selected for resistance to G418. Six of these clones contained levels of GST-pi that were 8- to 18-fold greater than GST levels found in mdr1-expressing clones transfected with nonspecific DNA. We found no difference in the degree of resistance to doxorubicin, actinomycin D, and vinblastine between the clones expressing mdr1 only and the clones expressing both mdr1 and GST-pi.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

编码一种假定的药物外排泵(P-糖蛋白)的mdr1基因的核苷酸序列与一类细菌膜相关转运蛋白同源。这些细菌蛋白是多组分系统的一部分,该系统包括结合底物的可溶性周质蛋白,以能量依赖的方式将它们引导穿过膜。我们研究了在最初因对阿霉素耐药而被选择的多药耐药人MCF-7乳腺癌细胞系(AdrR MCF-7)中是否存在类似的多组分转运系统的可能性。AdrR MCF-7细胞同时过度表达mdr1基因和谷胱甘肽S-转移酶(GST-pi)(EC 2.5.1.18)的pi类同工酶。后者是已知除具有药物代谢能力外还具有配体结合功能的几种同工酶之一。尽管我们最近表明,转染功能性GST-pi表达载体不足以使缺乏P-糖蛋白表达的细胞对阿霉素产生耐药性[《分子药理学》36:22 - 28(1989)],但我们研究了GST-pi与P-糖蛋白相互作用以改变多药耐药性的可能性。为此,我们从AdrR MCF-7细胞中克隆了编码这些蛋白的cDNA,构建了包含这两个基因的表达载体,并将这些载体依次转染到药物敏感的MCF-7细胞中。从AdrR MCF-7中分离出的人mdr1 cDNA是一个变异基因,其序列与先前从长春碱耐药的KB细胞中分离出的序列不同[《细胞》53:519 - 529(1989)],导致第893位氨基酸由丙氨酸替换为丝氨酸(mdr1/893ala)。转染包含从AdrR MCF-7细胞中分离出的mdr1基因的真核表达载体在受体细胞中产生了多药耐药表型,其交叉耐药模式与AdrR MCF-7细胞中的相似。为了确定GST-pi表达是否能增强mdr1提供的耐药性,两个转染了mdr1的克隆,一个高水平表达(AdR MCF-7细胞中mdr1 RNA的153%),一个低水平表达(AdrR MCF-7细胞中mdr1 RNA的10%),随后与GST-pi表达载体和pSVNeo共转染,并选择对G418耐药。这些克隆中有六个所含的GST-pi水平比用非特异性DNA转染的表达mdr1的克隆中发现的GST水平高8至18倍。我们发现仅表达mdr1的克隆与同时表达mdr1和GST-pi的克隆在对阿霉素、放线菌素D和长春碱的耐药程度上没有差异。(摘要截短至400字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验